Advertisement
Screener

AMICUS THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

AMICUS THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

AMICUS THERAPEUTICS, INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $10.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-03.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2014-03-03

  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2012-12-31 was -$2.60M.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2012-09-30 was $600.00K, a 82.35% decline year-over-year.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2012-06-30 was $100.00K.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2011-12-31 was -$4.80M.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2013 was $10.00M.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2012 was -$700.00K.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2011 was -$2.80M, a 300.00% decline from fiscal 2010.
  • AMICUS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2010 was $1.40M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month
2013-12-31$10.00M
10-K · filed 2014-03-03
2012-12-31-$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
-$2.00M
derived: sum of 2 quarters · filed 2014-03-03
-$1.90M
derived: sum of 3 quarters · filed 2014-03-03
-$700.00K
10-K · filed 2014-03-03
2012-09-30$600.00K
10-Q · filed 2012-11-06
$700.00K
derived: sum of 2 quarters · filed 2012-11-06
$1.90M
10-Q · filed 2012-11-06
2012-06-30$100.00K
10-Q · filed 2012-08-08
$2.50M
10-Q · filed 2012-08-08
2011-12-31-$4.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13
-$1.40M
derived: sum of 2 quarters · filed 2013-03-13
-$3.50M
derived: sum of 3 quarters · filed 2013-03-13
-$2.80M
10-K · filed 2013-03-13
2011-09-30$3.40M
10-Q · filed 2012-11-06
$1.30M
derived: sum of 2 quarters · filed 2012-11-06
$2.00M
10-Q · filed 2012-11-06
2011-06-30-$2.10M
10-Q · filed 2012-08-08
$1.40M
10-Q · filed 2012-08-08
2010-12-31$1.40M
10-K · filed 2013-03-13